Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats

N Shimizu1, M Yoshiyama, T Omura

  • 1First Department of Internal Medicine, Osaka City University Medical School, Japan.

Abstract

Insights

Myocardial infarction activates mitogen-activated protein kinases (MAPK), leading to increased activator protein-1 (AP-1) and nuclear factor-kB (NF-kB) DNA binding. This pathway promotes the expression of TGF-beta-1 and collagen, contributing to cardiac injury.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Signal Transduction

Background:

  • Myocardial infarction (MI) triggers complex cellular responses.
  • Signal transduction pathways, including mitogen-activated protein kinases (MAPK), activator protein-1 (AP-1), and nuclear factor-kB (NF-kB), are implicated in cardiac remodeling post-MI.

Purpose of the Study:

  • To investigate the activation of MAPK, AP-1, and NF-kB DNA binding activities following myocardial infarction in a rat model.
  • To understand the role of these signaling pathways in the early stages of cardiac injury and subsequent gene expression changes.

Main Methods:

  • Myocardial infarction was induced in Wistar rats.
  • MAPK activities were measured using in-gel or in vitro kinase assays.
  • AP-1 and NF-kB DNA binding were assessed via electrophoretic mobility shift assays.
  • mRNA levels of TGF-beta-1, collagen I, and collagen III were quantified using Northern blot hybridization.

Main Results:

  • MAPK activities (ERK, p38MAPK, JNK) showed rapid, transient increases within minutes to hours post-MI.
  • AP-1 and NF-kB DNA binding activities significantly increased by 3 days, returning to baseline by 7 days.
  • mRNA levels of TGF-beta-1, collagen I, and collagen III were markedly elevated by 1 week after MI.

Conclusions:

  • Myocardial ischemia activates MAPK signaling, subsequently enhancing AP-1 and NF-kB DNA binding activity in the infarcted region.
  • These activated signal transduction pathways are proposed to mediate increased expression of TGF-beta-1, collagen I, and collagen III, contributing to myocardial injury.